Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Community-based Care Coordination and Treatment Retention in Opioid Use Disorder: A 5-year Retrospective Cohort Study.

Journal of addiction medicine·2026

Same author

Determinants of Severe Financial Distress in U.S. Acute Care Hospitals: A National Longitudinal Study.

Healthcare (Basel, Switzerland)·2026

Same author

Retention on Buprenorphine for Opioid Use Disorder in Justice-Involved Individuals: A Retrospective Cohort Study.

Behavioral sciences (Basel, Switzerland)·2026

Same author

Disposition Outcomes Following Prehospital Use of Naloxone in a Large Metropolitan City in the United States.

Prehospital emergency care·2024

Same author

How Financial Beliefs and Behaviors Influence the Financial Health of Individuals Struggling with Opioid Use Disorder.

Behavioral sciences (Basel, Switzerland)·2024

Same author

The Impact of COVID-19 on the Financial Performance of Largest Teaching Hospitals.

Healthcare (Basel, Switzerland)·2023

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Strategic performance evaluation in cancer centers.

Rigoberto I Delgado¹, James R Langabeer

¹Fleming Center for Healthcare Management, University of Texas School of Public Health, Houston, Texas, USA. Rigoberto.I.Delgado@uth.tmc.edu

Journal of Healthcare Management / American College of Healthcare Executives

|January 16, 2010

Summary

High-performing cancer centers utilize advanced analytical methods and invest more in performance analysis for strategic control. This study highlights the critical role of robust strategic assessment in achieving organizational goals in healthcare.

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Jun 17, 2026

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Area of Science:

Healthcare Management
Strategic Planning
Oncology Services

Background:

Limited research exists on the post-implementation control and evaluation of healthcare strategies.
Strategic control is crucial for achieving organizational goals in healthcare settings.
Focus on oncology services offers insights into specialized healthcare strategy.

Purpose of the Study:

To identify strategic control approaches in major U.S. cancer centers.
To correlate strategic control practices with financial performance.
To enhance healthcare strategy theory and practice for focused services like oncology.

Main Methods:

A 17-question survey was designed to collect data on strategy and performance.
The study sample comprised major cancer hospitals in the United States.
Data captured elements of strategy formulation, implementation, and control.

Main Results:

High-performing cancer centers employ more sophisticated analytical approaches to strategy.
Leading cancer centers allocate greater financial resources to performance analysis.
Frequent performance reviews are characteristic of high-performing organizations.

Conclusions:

A more robust approach to strategic assessment is needed in healthcare.
Effective strategic control practices are linked to superior financial performance in cancer centers.
Recommendations are provided for management to improve strategic plan achievement.